APA (7th ed.) Citation

ZT, C., L, H., XD, Z., N, W., XM, J., XJ, W., . . . WY, L. (2026). Synergistic adverse prognostic impact of CD30 and Epstein-Barr virus in peripheral T-cell lymphoma: CD30 identifies a high-risk subgroup in Epstein-Barr virus-encoded RNA -positive patients. Annals of hematology, 105(4), 116. https://doi.org/10.1007/s00277-026-06782-y

Chicago Style (17th ed.) Citation

ZT, Chen, et al. "Synergistic Adverse Prognostic Impact of CD30 and Epstein-Barr Virus in Peripheral T-cell Lymphoma: CD30 Identifies a High-risk Subgroup in Epstein-Barr Virus-encoded RNA -positive Patients." Annals of Hematology 105, no. 4 (2026): 116. https://doi.org/10.1007/s00277-026-06782-y.

MLA (9th ed.) Citation

ZT, Chen, et al. "Synergistic Adverse Prognostic Impact of CD30 and Epstein-Barr Virus in Peripheral T-cell Lymphoma: CD30 Identifies a High-risk Subgroup in Epstein-Barr Virus-encoded RNA -positive Patients." Annals of Hematology, vol. 105, no. 4, 2026, p. 116, https://doi.org/10.1007/s00277-026-06782-y.